| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMA/211884/2012 (27.3.12) |
| Publication Date | 27/03/2012 |
| Content Type | News |
|
The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), in March 2012, adopted a joint guidance document, providing for the first time for a consistent Europe-wide approach to the identification of commercially confidential information and personal data in a marketing authorisation application. |
|
| Source Link | Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/03/news_detail_001478.jsp&mid=WC0b01ac058004d5c1 |
| Related Links |
|
| Subject Categories | Business and Industry, Health |
| Countries / Regions | Europe |